Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Metabolomics ; 16(1): 13, 2020 01 10.
Artigo em Inglês | MEDLINE | ID: mdl-31925544

RESUMO

INTRODUCTION: Acute myeloid leukemia (AML) is characterized by a set of malignant proliferations leading to an accumulation of blasts in the bone marrow and blood. The prognosis is pejorative due to the molecular complexity and pathways implicated in leukemogenesis. OBJECTIVES: Our research was focused on comparing the metabolic profiles of leukemic cells in basal culture and deprivation conditions to investigate their behaviors under metabolic stress. METHODS: We performed untargeted metabolomics using 1H HRMAS-NMR. Five human leukemic cell lines-KG1, K562, HEL, HL60 and OCIAML3-were studied in the basal and nutrient deprivation states. A multivariate analysis of the metabolic profile was performed to find over- or under- expressed metabolites in the different cell lines, depending on the experimental conditions. RESULTS: In the basal state, each leukemic cell line exhibited a specific metabolic signature related to the diversity of AML subtypes represented and their phenotypes. When cultured in a serum-free medium, they showed quick metabolic adaptation and continued to proliferate and survive despite the lack of nutrients. Low apoptosis was observed. Increased phosphocholine and glutathione was a common feature of all the observed cell lines, with the maximum increase in these metabolites at 24 h of culture, suggesting the involvement of lipid metabolism and oxidative stress regulators in the survival mechanism developed by the leukemic cells. CONCLUSIONS: Our study provides new insights into the metabolic mechanisms in leukemogenesis and suggests a hierarchy of metabolic pathways activated within leukemic cells, some dependent on their genotypes and others conserved among the subtypes but commonly induced under micro-environmental stress.


Assuntos
Genótipo , Leucemia/metabolismo , Redes e Vias Metabólicas , Estresse Fisiológico , Linhagem Celular Tumoral , Meios de Cultura Livres de Soro/efeitos adversos , Humanos , Leucemia/genética , Metaboloma
2.
FEBS J ; 285(3): 531-541, 2018 02.
Artigo em Inglês | MEDLINE | ID: mdl-29222853

RESUMO

Human embryonic stem cells (hESCs) are extremely delicate, and survive poorly under suboptimal culture conditions, severely restricting long-term studies and practical applications. Thus, a protective agent that promotes stem cell survival is urgently needed. In this study, we evaluated the protective effects of stemazole in single-cell and starved hESC cultures. Colony formation was quantified by alkaline phosphatase and immunofluorescence staining, while apoptosis was assessed by flow cytometry and TUNEL assay. Expression of hESC and other stem cell markers was evaluated by western blot, RT-PCR, and qPCR. We found that stemazole enhanced clonal expansion from single cells in dose-dependent fashion and clearly decreased apoptosis from 54.1% to 25.2%. Furthermore, the drug reduced apoptosis from 43.6% to 8.4% over 15 h of starvation, with 66% of stemazole-treated cells remaining viable after 2 weeks of starvation. Importantly, starved cells protected with stemazole retained the same proliferation and differentiation properties as cells in normal culture. In conclusion, stemazole significantly promotes survival of stem cells in single-cell or starvation cultures without compromising stemness and pluripotency.


Assuntos
Células-Tronco Embrionárias Humanas/efeitos dos fármacos , Hidrazinas/farmacologia , Oxidiazóis/farmacologia , Substâncias Protetoras/farmacologia , Apoptose/efeitos dos fármacos , Biomarcadores/metabolismo , Diferenciação Celular/efeitos dos fármacos , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Técnicas de Cocultura , Ensaio de Unidades Formadoras de Colônias , Meios de Cultura Livres de Soro/efeitos adversos , Corpos Embrioides/citologia , Corpos Embrioides/efeitos dos fármacos , Corpos Embrioides/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Células-Tronco Embrionárias Humanas/citologia , Células-Tronco Embrionárias Humanas/metabolismo , Humanos , Hidrazinas/química , Células-Tronco Pluripotentes Induzidas/citologia , Células-Tronco Pluripotentes Induzidas/efeitos dos fármacos , Células-Tronco Pluripotentes Induzidas/metabolismo , Estrutura Molecular , Concentração Osmolar , Oxidiazóis/química , Relação Quantitativa Estrutura-Atividade , Análise de Célula Única
3.
Hum Fertil (Camb) ; 21(3): 174-182, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28589740

RESUMO

Scientists working in assisted reproduction [members of Scientists in Reproductive Technology (SIRT) Australia, and subscribers of the online forums EmbryoMail and Quartec] were invited to complete an online questionnaire on the use of human blood products in assisted reproductive technologies (ART). A total of 260 started the questionnaire, with 208 (80%) completing it. A total of 62% of respondents had worked in human ART ≥8 years and 68% had post-graduate qualifications. The majority (82%) reported using products of animal or human origin, with 75% knowing why protein was added to culture media and 41% not worried by this. Almost half (49%) of respondents were unaware of regulations surrounding the use of human blood products in health care and 70% were unaware of adverse events involving human blood products in human ART. Most respondents (70%) indicated that they were not concerned about infections such as hepatitis, but agents such as prions were a cause for concern (57%). A total of 57% of respondents were unaware of alternatives, but 77% would use a suitable alternative. Using blood products in human ART is surrounded by a lack of awareness, often independent of respondents' qualifications or experience. A better understanding of these products and possible alternatives is required if informed decisions about their suitability are to be made.


Assuntos
Atitude do Pessoal de Saúde , Sangue , Procedimentos Médicos e Cirúrgicos sem Sangue , Infecção Hospitalar/prevenção & controle , Meios de Cultura/efeitos adversos , Conhecimentos, Atitudes e Prática em Saúde , Técnicas de Reprodução Assistida/efeitos adversos , Animais , Austrália/epidemiologia , Pesquisa Biomédica , Sangue/virologia , Procedimentos Médicos e Cirúrgicos sem Sangue/educação , Infecção Hospitalar/etiologia , Infecção Hospitalar/virologia , Meios de Cultura/normas , Meios de Cultura Livres de Soro/efeitos adversos , Meios de Cultura Livres de Soro/normas , Feminino , Pesquisas sobre Atenção à Saúde , Hepatite/epidemiologia , Hepatite/etiologia , Hepatite/prevenção & controle , Humanos , Internet , Masculino , Pessoal de Laboratório Médico/educação , Avaliação das Necessidades , Doenças Priônicas/epidemiologia , Doenças Priônicas/etiologia , Doenças Priônicas/prevenção & controle , Doenças Priônicas/transmissão , Técnicas de Reprodução Assistida/normas , Risco , Albumina Sérica Humana/efeitos adversos , Recursos Humanos
4.
JAMA Ophthalmol ; 132(7): 832-7, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24789459

RESUMO

IMPORTANCE: Optisol-GS, the most common corneal storage medium in the United States, contains antibacterial but no antifungal supplementation. Most postkeratoplasty endophthalmitis and keratitis cases are now of a fungal origin. OBJECTIVE: To assess the efficacy and safety of voriconazole and amphotericin B in reducing Candida species contamination of Optisol-GS under normal storage conditions. DESIGN, SETTING, AND PARTICIPANTS: In vitro laboratory study using 15 pairs of research-grade donor corneas and 20-mL vials of Optisol-GS. INTERVENTIONS: Twenty vials of Optisol-GS were supplemented with either voriconazole at 1×, 10×, 25×, or 50× minimum inhibitory concentration (MIC) or amphotericin B at 0.25×, 0.5×, 1×, or 10× MIC. Known concentrations of Candida albicans and Candida glabrata were each added to a set of vials. Safety studies were performed by separating 15 pairs of donor corneas into unsupplemented Optisol-GS or Optisol-GS plus an antifungal. MAIN OUTCOMES AND MEASURES: Efficacy outcomes were viable fungal colony counts determined from samples taken on days 2, 7, and 14 immediately after removal from refrigeration and after warming to room temperature for 2 hours. Safety outcomes included percentage of intact epithelium and endothelial cell density on days 0, 7, and 14, as well as percentage of nonviable endothelial cells by vital dye staining on day 14. RESULTS: Growth of C albicans and C glabrata was observed in all voriconazole-supplemented vials. In contrast, there was no growth of either organism in amphotericin B-supplemented vials, except at 0.25× and 0.5× MIC on day 2, when viable counts of C glabrata were reduced by 99% and 96%, respectively. Compared with paired controls, with the exception of Optisol-GS plus amphotericin B at 10× MIC, donor corneas in supplemented Optisol-GS appeared to have no difference in endothelial cell density reduction, percentage of intact epithelium, or percentage of nonviable endothelial cells. CONCLUSIONS AND RELEVANCE: The addition of amphotericin B to Optisol-GS may significantly improve activity against contamination with Candida species, the primary cause of fungal infection after corneal transplantation. This study found significant endothelial toxic effects at the maximal concentration of amphotericin B.


Assuntos
Antifúngicos/farmacologia , Candidíase/prevenção & controle , Sulfatos de Condroitina/farmacologia , Córnea , Dextranos/farmacologia , Contaminação de Medicamentos/prevenção & controle , Gentamicinas/farmacologia , Soluções para Preservação de Órgãos/farmacologia , Anfotericina B/efeitos adversos , Anfotericina B/farmacologia , Antifúngicos/efeitos adversos , Candida albicans/efeitos dos fármacos , Candida glabrata/efeitos dos fármacos , Candidíase/microbiologia , Contagem de Células , Sulfatos de Condroitina/efeitos adversos , Contagem de Colônia Microbiana , Misturas Complexas/efeitos adversos , Misturas Complexas/farmacologia , Meios de Cultura Livres de Soro/efeitos adversos , Meios de Cultura Livres de Soro/farmacologia , Dextranos/efeitos adversos , Combinação de Medicamentos , Endotélio Corneano/efeitos dos fármacos , Endotélio Corneano/microbiologia , Endotélio Corneano/patologia , Gentamicinas/efeitos adversos , Humanos , Testes de Sensibilidade Microbiana , Preservação de Órgãos , Soluções para Preservação de Órgãos/efeitos adversos , Pirimidinas/efeitos adversos , Pirimidinas/farmacologia , Doadores de Tecidos , Resultado do Tratamento , Triazóis/efeitos adversos , Triazóis/farmacologia , Voriconazol
5.
Antimicrob Agents Chemother ; 55(7): 3099-104, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21502622

RESUMO

It is generally accepted that only the unbound fraction of a drug is pharmacologically active. Posaconazole is an antifungal agent with a protein binding of 98 to 99%. Taking into account the degree of protein binding, plasma levels in patients, and MIC levels of susceptible strains, it can be assumed that the free concentration of posaconazole sometimes will be too low to exert the expected antifungal effect. The aim was therefore to test the activity of posaconazole in serum in comparison with that of the calculated unbound concentrations in protein-free media. Significant differences (P < 0.05) from the serum control were found at serum concentrations of posaconazole of 1.0 and 0.10 mg/liter, with calculated free concentrations corresponding to 1× MIC and 0.1× MIC, respectively, against one Candida lusitaniae strain selected for proof of principle. In RPMI 1640, the corresponding calculated unbound concentration of 0.015 mg/liter resulted in a significant effect, whereas that of 0.0015 mg/liter did not. Also, against seven additional Candida strains tested, there was an effect of the low posaconazole concentration in serum, in contrast to the results in RPMI 1640. Fluconazole, a low-grade-protein-bound antifungal, was used for comparison at corresponding concentrations in serum and RPMI 1640. No effect was observed at the serum concentration, resulting in a calculated unbound concentration of 0.1× MIC. In summary, there was a substantially greater pharmacodynamic effect of posaconazole in human serum than could be predicted by the non-protein-bound serum concentration. A flux from serum protein-bound to fungal lanosterol 14α-demethylase-bound posaconazole is suggested.


Assuntos
Antifúngicos/farmacocinética , Triazóis/farmacocinética , Antifúngicos/farmacologia , Candida/efeitos dos fármacos , Meios de Cultura Livres de Soro/efeitos adversos , Humanos , Testes de Sensibilidade Microbiana , Ligação Proteica/efeitos dos fármacos , Soro , Triazóis/farmacologia
6.
Brain Res ; 1367: 33-42, 2011 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-20970407

RESUMO

Identifying small molecules that suppress apoptosis is promising for the therapy of brain diseases. We recently showed that autocrine bone morphogenetic protein (BMP) signaling involves the effects of cholesterol myristate present in traditional Chinese medicine on mesenchymal stem cells. The present study evaluated the effects of cholesterol myristate on the apoptosis and BMP signaling of PC12 cells. PC12 cells transfected by the inhibitor of differentiation (Id1) promoter reporter construct target gene of BMP4 signaling; cholesterol myristate increases the activity of Id1 promoter. However, structurally related steroids such as cholesterol, ß-sitosterol and cholesten-3-one, lack of the myristate, did not affect the activity of Id1 promoter, suggesting that myristate is essential for the effect of cholesterol myristate. These effects depend on BMP signaling. Apoptosis analysis indicated that cholesterol myristate inhibited the apoptosis of PC12 cells induced in serum-free condition. Cholesterol myristate significantly increases the expression of BMP4, BMPRIA, p-Smad1/5/8, Id1 and its antiapoptotic target gene Bcl-xL in PC12 cells treated in serum-free condition. Moreover, BMP antagonist reduced the anti-apoptotic effect of cholesterol myristate. Thus, this study is to provide evidence that BMP-Id pathway targeted by cholesterol myristate suppresses the apoptosis of PC12 cells. Our findings are therefore of considerable therapeutic significance and provide the potential of newly exploiting cholesterol myristate and clinically in brain disease therapies.


Assuntos
Apoptose/efeitos dos fármacos , Proteína Morfogenética Óssea 4/metabolismo , Colesterol/farmacologia , Proteína 1 Inibidora de Diferenciação/metabolismo , Ácido Mirístico/farmacologia , Transdução de Sinais/efeitos dos fármacos , Animais , Anticorpos/farmacologia , Proteína Morfogenética Óssea 4/imunologia , Receptores de Proteínas Morfogenéticas Ósseas/metabolismo , Meios de Cultura Livres de Soro/efeitos adversos , Relação Dose-Resposta a Droga , Regulação da Expressão Gênica/efeitos dos fármacos , Ácido Mirístico/química , Células PC12 , Regiões Promotoras Genéticas/efeitos dos fármacos , RNA Mensageiro , Ratos , Fatores de Tempo , Transfecção/métodos
7.
Epilepsy Res ; 92(2-3): 153-62, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20851574

RESUMO

Epileptic seizures typically result in delayed neuronal loss secondary to the initial damage and an up-regulation in connexin43 (Cx43). This study investigated the role of Cx43 gap junctions in lesion spread and cell loss following epileptiform activity. Epileptiform injury in hippocampal slice cultures was induced by 48 h exposure to 100 µM bicuculline methochloride (BMC). During the 24h recovery period following BMC treatment, lesion spread was observed in the CA1. A Cx43 mimetic peptide, applied during either the BMC treatment or recovery periods, produced concentration- and exposure time-dependent neuroprotection, as measured by propidium iodide uptake at the end of the recovery period. During the BMC period, peptide concentrations between 5 and 50 µM (sufficient to block hemichannels) had a protective effect while a substantial gap junction blockade with 500 µM peptide exacerbated the lesion. By contrast, all doses applied during the recovery period protected the CA1 region from further damage. The results indicate that while the slices are undergoing excessive neuronal firing and epileptic stress, gap junction communication appears to be essential for tissue survival but hemichannel opening may be damaging. Following epileptiform insult, however, gap junction communication plays a crucial role in the spread of neuronal damage. The findings from this study identify gap junction communication as a potential therapeutic target for epilepsy.


Assuntos
Região CA1 Hipocampal/patologia , Conexina 43/farmacologia , Degeneração Neural/prevenção & controle , Animais , Animais Recém-Nascidos , Bicuculina/efeitos adversos , Bicuculina/análogos & derivados , Região CA1 Hipocampal/efeitos dos fármacos , Morte Celular/efeitos dos fármacos , Meios de Cultura Livres de Soro/efeitos adversos , Relação Dose-Resposta a Droga , Antagonistas GABAérgicos/efeitos adversos , Técnicas In Vitro , Proteínas Associadas aos Microtúbulos/metabolismo , Degeneração Neural/etiologia , Peptídeos/química , Peptídeos/farmacologia , Ratos , Ratos Wistar , Fatores de Tempo
8.
Mol Cell Biochem ; 337(1-2): 159-66, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19851832

RESUMO

Endothelium-derived nitric oxide (NO) is a cytoprotective molecule to prevent endothelial cells (ECs) from apoptosis. CREB-binding protein (CBP) is involved in the apoptotic pathway in several tumor cells, however, little is known whether CBP is associated with apoptosis in ECs and the apoptotic effect of CBP on ECs is regulated by NO. Therefore, the purpose of the present study was to investigate whether silencing CBP expression could affect the sensitivity of ECs toward apoptotic stimuli and determined the role of NO. In this study, we found that when CBP expression was silenced by RNA interference, ECs were more prone to apoptosis under serum deprivation, whereas the apoptosis was not significantly induced in the serum-containing condition. The increased apoptosis is paralleled by a reduction of NO, and the apoptosis was reversed by NO donors, suggesting an important role of NO. Furthermore, CBP silencing decreased NO production by downregulating the endothelial NO synthase (eNOS) expression in a dose-dependent manner. These results indicated that CBP silencing is associated with decreased eNOS expression and NO production, and therefore concomitantly increased the sensitivity of ECs toward apoptosis.


Assuntos
Apoptose/efeitos dos fármacos , Apoptose/genética , Proteína de Ligação a CREB/genética , Meios de Cultura Livres de Soro/farmacologia , Células Endoteliais/efeitos dos fármacos , Óxido Nítrico/fisiologia , Animais , Proteína de Ligação a CREB/antagonistas & inibidores , Meios de Cultura Livres de Soro/efeitos adversos , Regulação para Baixo/fisiologia , Células Endoteliais/metabolismo , Células Endoteliais/fisiologia , Regulação Enzimológica da Expressão Gênica/efeitos dos fármacos , Masculino , Óxido Nítrico/metabolismo , Óxido Nítrico/farmacologia , Doadores de Óxido Nítrico/farmacologia , Óxido Nítrico Sintase Tipo III/genética , Óxido Nítrico Sintase Tipo III/metabolismo , Nitroprussiato/farmacologia , Interferência de RNA/fisiologia , RNA Interferente Pequeno/farmacologia , Ratos , Ratos Sprague-Dawley , S-Nitroso-N-Acetilpenicilamina/farmacologia
9.
Mol Ther ; 13(2): 366-73, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16325473

RESUMO

DNA integration is a defining step in the retroviral life cycle and the basis of stable gene transfer in retrovirus-based gene therapy. Previous studies of integration by HIV-based vectors have shown that integration is not random, but favored in active transcription units. Studies to date have focused on HIV integration in dividing cells, leaving open the question of whether integration target site selection might differ in nondividing cells. According to one idea, division of the host cell might be required for favored integration in transcription units, possibly as a result of chromatin remodeling during DNA replication. Here we have investigated this issue by comparing integration in dividing IMR-90 primary lung fibroblasts to integration in nondividing IMR-90 cells arrested in G1 by serum starvation and contact inhibition. We identified several differences in integration site selection in arrested versus dividing cells, including the frequency of integration in transcription units and in gene-rich regions. However, integration in nondividing cells was in fact more favored in transcription units, contrary to the idea that cell division was important for this bias. These data provide the first view of lentiviral integration in nondividing cells and help constrain models for the mechanism of favored integration in genes.


Assuntos
Divisão Celular/genética , Inibição de Contato/genética , Fibroblastos/virologia , Vetores Genéticos , HIV/genética , Pulmão/citologia , Pulmão/virologia , Integração Viral/genética , Linhagem Celular , Meios de Cultivo Condicionados , Meios de Cultura Livres de Soro/efeitos adversos , Fibroblastos/citologia , Fibroblastos/metabolismo , Fase G1/genética , Regulação Viral da Expressão Gênica/fisiologia , Humanos , Pulmão/metabolismo , Dados de Sequência Molecular , Transcrição Gênica/fisiologia
10.
Naunyn Schmiedebergs Arch Pharmacol ; 364(2): 96-104, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11534860

RESUMO

We tested the potential cytoprotective role of C-phycocyanin in rat cerebellar granule cell cultures. Cell death was induced by potassium and serum (K/S) withdrawal. Cell viability was studied using the neutral red assay and laser scanning cytometry with propidium iodide as fluorochrome. C-phycocyanin (1-3 mg/ml) showed a neuroprotective effect against 24 h of K/S deprivation in cerebellar granule cells. After 4 h K/S deprivation this compound (3 mg/ml) inhibited formation of reactive oxygen species, measured as 2',7'-dichlorofluorescein fluorescence, showing its scavenger capability. Pre-treatment with C-phycocyanin reduced thymidine incorporation into DNA below control values and reduced dramatically apoptotic bodies as visualized by propidium iodide, indicating inhibition of apoptosis induced by K/S deprivation. Flow cytometry studies, using propidium iodide in TritonX100 permeabilized cells, indicated that 24 h K/S deprivation acts as a proliferative signal for cerebellar granule cells, which show an increase in S-phase percentage and cells progressed into the apoptotic pathway. C-phycocyanin protected cerebellar granule cells from the apoptosis induced by deprivation. These results suggest that C-phycocyanin prevents apoptosis in cerebellar granule cells probably through the antioxidant activity. It is proposed that K/S deprivation-induced apoptosis could be due, in part, to an alteration in the cell cycle mediated by an oxidative stress mechanism.


Assuntos
Apoptose/efeitos dos fármacos , Cerebelo/citologia , Cerebelo/efeitos dos fármacos , Fármacos Neuroprotetores/farmacologia , Ficocianina/farmacologia , Cloreto de Potássio/administração & dosagem , Animais , Animais Recém-Nascidos , Apoptose/fisiologia , Ciclo Celular/efeitos dos fármacos , Ciclo Celular/fisiologia , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/fisiologia , Células Cultivadas , Cerebelo/metabolismo , Meios de Cultura Livres de Soro/efeitos adversos , Ratos , Ratos Sprague-Dawley , Espécies Reativas de Oxigênio/metabolismo
11.
J Cell Sci ; 110 ( Pt 7): 819-28, 1997 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-9133669

RESUMO

AKR-2B cells disintegrate after serum removal. After a delay of approximately 90 minutes, cell death began and reached after six hours a plateau of 40-50% remaining living cells. We used time-lapse video microscopy to monitor dynamic structural changes and to measure the time span of individual cells to die. The first change was the rapid appearance of membrane blebs. Membrane vesicles were rapidly extruded and reintegrated by the cell. This highly dynamic process of an affected cell stopped after 80+/-20 minutes with its death. Conductivity measurements showed that at that time the membrane was electrically permeable. By using fluorescence double staining with propidium iodide and Hoechst 33258, we show that membrane leakage leading to disintegration is accompanied, and for some cells preceded, by nuclear condensation. The energy state of the intact cells was monitored by measuring the intracellular ATP content which remained high (6 mM) throughout the entire time of investigation. Mitochondrial potential was determined by rhodamine 123 fluorescence in parallel to the measurement of membrane permeability via uptake of propidium iodide and lead to the detection of a cell population that exhibits a high mitochondrial potential and an uptake of propidium iodide indicating a membrane disruption of cells which still have a high energy charge. It is shown by electron microscopy that mitochondria were swollen and damaged in parallel to nuclear condensation. There was no DNA fragmentation as shown by two independent methods. Addition of the ICE-like protease inhibitor tyr-val-ala-asp-chloromethylketone immediately after serum starvation lead to an almost complete survival of the cells up to 6 hours. A pronounced protection was still observed after 24 hours, suggesting an involvement of this type of protease in the onset of cell death after serum removal. Apparently, serum withdrawal activates a succession of initial events that are similar to those defined as 'apoptosis', i.e. nuclear condensation and membrane blebbing. These steps are, however, accompanied or rapidly followed by cell lysis and disruption of mitochondria, both of which are characteristic of necrosis.


Assuntos
Apoptose/fisiologia , Fibroblastos/fisiologia , Necrose , Nucleotídeos de Adenina/análise , Animais , Caspase 1 , Contagem de Células , Núcleo Celular/fisiologia , Células Cultivadas , Meios de Cultura Livres de Soro/efeitos adversos , Cisteína Endopeptidases/fisiologia , Fragmentação do DNA , Fibroblastos/ultraestrutura , Camundongos , Microscopia Eletrônica , Microscopia de Fluorescência , Microscopia de Vídeo , Mitocôndrias/fisiologia , Mitocôndrias/ultraestrutura , Ornitina Descarboxilase/metabolismo , Proteínas Proto-Oncogênicas c-fos/metabolismo , Proteínas Proto-Oncogênicas c-myc/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...